Solmi M
SCIENCES lab, Department of Psychiatry, Faculty of Medicine, University of Ottawa, Ontario, Canada.
ArticlePsilocybin
Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.
ArticlePsilocybin
Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution.
ArticlePsilocybin
Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
ArticlePsychedelics
Changes over time in hallucinogen-related emergency department visits in Ontario, Canada.
ArticlePsychedelics
Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study.
ArticleMDMA
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.
ArticlePsilocybin
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.
ArticlePsilocybin
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.
ArticlePsychedelics
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.
ArticlePsilocybin
Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.
ArticlePsilocybin
Psilocybin Dispensaries and Online Health Claims in Canada.
ArticlePsychedelics
Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population.
ArticlePsychedelics
Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder.
ArticlePsilocybin
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.
ArticlePsychedelics
The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication.
ArticlePsilocybin
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
ArticleKetamine